West Pharmaceutical Services, Inc.

WST Healthcare Medical Instruments & Supplies

West Pharmaceutical Services, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.1 billion, up 6.25% from fiscal 2024. In the quarter to June 2026, revenue grew 13.8%, EPS grew 19.2%, free cash flow fell 20.7% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years.

382.92 0.10 −0.03%
Market cap
$27.0B
P/E
48.7×
Fwd P/E
37.3×
Dividend yield
0.23%
F-score
8/9
Altman Z
13.89
Beneish M
−2.79
Dividend safety
100/100

West Pharmaceutical Services, Inc. 10-Q filed Jul 23, 2026

Fiscal Q2 2026 · Period ended Jun 30, 2026 · Filed · accepted 4:15 PM ET · Document on sec.gov · Filing index

What changed

Part I, Item 2, Management’s Discussion and Analysis, against the 10-Q filed Apr 23, 2026: 27 added · 5 removed · 26 modified; 16 with only figures updated

  1. Modified · Macroeconomic Factors

    Beginning in 2025, the U.S. government imposed additional tariffs and trade restrictions on certain goods produced outside of the United States. In response to these actions, and certain jurisdictions in which we operate have imposed or are considering imposing tariffs and restrictions on certain goods produced in the United States. In February 2026, the U.S. Supreme Court issued a ruling that certain tariffs imposed under the International Emergency Economics Power Act (“IEEPA”) were unauthorized. During the second quarter of 2026, the Company began applying for and receiving certain refunds for tariffs previously collected under the IEEPA. We continue to monitor this dynamic situation to assesstrade-policy environment, including the potential impact of these tariffs on our business and actions we can take to minimize their impactexisting or future tariffs, trade restrictions, retaliatory measures, available refund processes and mitigation actions. Based on the information available at this timecurrently available, we do not believe the impact will be expect these matters to have a material toimpact on our 2026 results.

57 more changes in this Item, word by word, in Powerpack.

Powerpack